drugset
drugset / Trial / NCT00287521

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00287521 ↗

Phase 2 Completed 87 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.

Timeline

Start
2005-11
Primary completion
2006-02
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject AL-37807 Unknown 1 % Other
Comparator Latanoprost Small molecule 0.005 % Other
Subject Timolol Other / unclassified 0.5 % Other

Indications

ocular hypertension open-angle glaucoma